Matthew Lunning, Matt Lunning, D.O., F.A.C.P.

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    EUSA
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Fate Therapetuics
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GenMab
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    InstilBio
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ipsen
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Kite
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Loxo
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Miltenyi
    Topic:
    honorarium/consulting
    Date added:
    05/05/2023
    Date updated:
    08/02/2024

Pages

Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes